Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

Completed · Phase 2

Conditions studied: Gastroenteritis

In brief

The purpose of this trial is to obtain serum for proficiency testing to confirm assay validity is maintained following the dosing of adults with a pediatric dose of HIL-214.

Key facts

Study ID
NCT05972733
Run by
HilleVax
People needed
80
Starts
2023-08-01
Expected to finish
2023-11-10
Last updated by the study team
2025-08-19

Who can join

Age: 18 and older, up to 49. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.